Lakewood Capital Management, LP Bausch Health Companies Inc. Transaction History

Lakewood Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $4.79 Million - $16 Million	-678,917 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $2.11 Million - $2.72 Million	-97,700 Reduced 12.58%	678,917 $15.5 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $1 Million - $1.2 Million	-40,000 Reduced 4.9%	776,617 $21.6 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $274,300 - $327,000	-10,000 Reduced 1.21%	816,617 $23.9 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $12.5 Million - $20.2 Million	-586,200 Reduced 41.49%	826,617 $26.2 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $372,000 - $503,250	25,000 Added 1.8%	1,412,817 $22 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $9.48 Million - $14.6 Million	712,472 Added 105.5%	1,387,817 $25.4 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $12.8 Million - $21.5 Million	675,345 New	675,345 $20.2 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Lakewood Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Lakewood Capital Management, LP with notifications on news.